Form 4: Bruker Corp CEO Frank H. Laukien Acquires Shares in Multiple Transactions

Bruker Corporation's CEO, Frank H. Laukien, has acquired a total of 99,999 shares of common stock through multiple transactions on November 18, 2024.

Summary

• Frank H. Laukien, the President and CEO of Bruker Corporation, has reported the acquisition of 99,999 shares of Bruker common stock on November 18, 2024.
• The shares were purchased in multiple transactions at weighted average prices of $49.82, $50.82, and $51.36.
• The total number of shares beneficially owned by Mr. Laukien after these transactions is 38,439,563 directly held shares.
• Mr. Laukien also has indirect beneficial ownership of shares through his former spouse, son, daughter, and as a UTMA custodian for his son.

Sentiment

Score: 7

Explanation: The document reflects a positive sentiment due to the CEO's share purchases, indicating confidence in the company. However, it is a routine filing and not a major event.

Positives

• The CEO's purchase of shares may indicate confidence in the company's future performance.
• The transactions show a significant investment by the CEO in the company's stock.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company executives.

Comparison to Industry Standards

• SEC Form 4 filings are standard practice for publicly traded companies in the United States, ensuring transparency of insider transactions.
• The reported transactions are typical for executives who may acquire shares as part of their compensation or personal investment strategies.
• The level of detail provided in the filing is consistent with SEC requirements for reporting beneficial ownership changes.

Stakeholder Impact

• The share purchases may positively influence investor confidence.
• The transactions do not have a direct impact on employees, customers, or suppliers.

Key Dates

Keywords

Bruker Corporation, Frank H. Laukien, share acquisition, insider trading, SEC Form 4, common stock, beneficial ownership